Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,771

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,874.2025.800.29%
CAC 408,106.160.000.00%
DAX 4024,076.87153.04-0.63%
Dow JONES (US)48,114.26302.30-0.62%
FTSE 1009,684.7966.52-0.68%
HKSE25,465.06229.650.91%
NASDAQ23,111.4654.050.23%
Nikkei 22549,512.28128.990.26%
NZX 50 Index13,295.91129.04-0.96%
S&P 5006,800.2616.25-0.24%
S&P/ASX 2008,585.2021.600.25%
SSE Composite Index3,870.2845.471.19%

Market Movers